Literature DB >> 17636731

Interventions for preventing posterior capsule opacification.

O Findl1, W Buehl, P Bauer, T Sycha.   

Abstract

BACKGROUND: Posterior capsule opacification (PCO) remains the most common long-term complication after cataract surgery. It can be treated by Nd:YAG laser capsulotomy, however, this may lead to other complications and laser treatment is not available in large parts of the developing world. Therefore, many studies try to find factors influencing the development of PCO.
OBJECTIVES: To summarise the effects of different interventions to inhibit PCO. These include modifications of surgical technique and intraocular lens (IOL) design, implantation of additional devices and pharmacological interventions. SEARCH STRATEGY: We searched CENTRAL, MEDLINE, EMBASE, LILACS in January 2007 and reference lists of identified trial reports. SELECTION CRITERIA: We included only prospective, randomised and controlled trials with a follow-up time of at least 12 months. Interventions included modifications in surgical technique explicitly to inhibit PCO, modifications in IOL design (material and geometry), implantation of additional devices, and pharmacological therapy, compared to each other, placebo or standard treatment. DATA COLLECTION AND ANALYSIS: Data were extracted and entered into Review Manager. Visual acuity data, PCO score and YAG capsulotomy rates were compared and a meta-analysis was performed when possible. MAIN
RESULTS: Fifty three studies were included in the review. The review was divided into three parts. (1) Influence of IOL optic material on the development of PCO. Compared to other materials, the meta-analysis of the included studies showed a significantly higher PCO score (overall effect: 12.39 (95% confidence interval: 9.82 to 14.95), scale 0 to 100) and YAG rate (odds ratio: 8.37 (3.74 to 20.36)) only in hydrogel IOLs. (2) Influence of IOL optic design on the development of PCO. There was a significantly lower PCO score (-8.65 (-10.72 to -6.59), scale 0 to 100) and YAG rate (0.19 (0.11 to 0.35)) in sharp edged than in round edged IOLs, however, not between 1-piece and 3-piece IOLs. (3) Influence of surgical technique and drugs on the development of PCO. There was no significant difference between different types of intra-/postoperative anti-inflammatory treatment except for treatment with an immunotoxin (MDX-A) leading to a significantly lower PCO rate. AUTHORS'
CONCLUSIONS: Due to the highly significant difference between round and sharp edge IOL optics, IOLs with sharp (posterior) optic edges should be preferred. There is no clear difference between optic materials, except for hydrogel IOLs, that showed more PCO than the other materials. The choice of postoperative anti-inflammatory treatment does not seem to influence PCO development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636731     DOI: 10.1002/14651858.CD003738.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  15 in total

1.  [Intraocular lenses for microincisional cataract surgery].

Authors:  T Kohnen; O K Klaproth
Journal:  Ophthalmologe       Date:  2010-02       Impact factor: 1.059

2.  Influence of super-hydrophobic silicone rubber substrate on the growth and differentiation of human lens epithelial cells.

Authors:  Liuxueying Zhong; Jiayi Jin; Danying Zheng; Weisheng Guan; Yue Guo; Anfu Chen; Yujiang Peng; Qianying Gao; Yongxin Zheng; Hanxiong Huang
Journal:  J Mater Sci Mater Med       Date:  2018-11-13       Impact factor: 3.896

3.  Acute effects of the sigma-2 receptor agonist siramesine on lysosomal and extra-lysosomal proteolytic systems in lens epithelial cells.

Authors:  S Jonhede; A Petersen; M Zetterberg; J-O Karlsson
Journal:  Mol Vis       Date:  2010-05-08       Impact factor: 2.367

4.  Intraocular lenses for the treatment of age-related cataracts: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-10-01

5.  Cochrane systematic reviews and co-publication: dissemination of evidence on interventions for ophthalmic conditions.

Authors:  Xue Wang; Barbara S Hawkins; Kay Dickersin
Journal:  Syst Rev       Date:  2015-09-22

Review 6.  Does Posterior Capsule Opacification Affect the Results of Diagnostic Technologies to Evaluate the Retina and the Optic Disc?

Authors:  Jose Javier Garcia-Medina; Monica Del Rio-Vellosillo; Vicente Zanon-Moreno; Enrique Santos-Bueso; Roberto Gallego-Pinazo; Antonio Ferreras; Maria Dolores Pinazo-Duran
Journal:  Biomed Res Int       Date:  2015-06-08       Impact factor: 3.411

7.  In vitro growth of lens epithelial cells from cataract patients - association with possible risk factors for posterior capsule opacification.

Authors:  Karin Sundelin; Anne Petersen; Yalda Soltanpour; Madeleine Zetterberg
Journal:  Open Ophthalmol J       Date:  2014-05-30

8.  Clinical consequences of acrylic intraocular lens material and design: Nd:YAG-laser capsulotomy rates in 3 x 300 eyes 5 years after phacoemulsification.

Authors:  Björn Johansson
Journal:  Br J Ophthalmol       Date:  2009-10-14       Impact factor: 4.638

9.  Modelling lifetime cost consequences of ReSTOR in cataract surgery in four European countries.

Authors:  Antoine Lafuma; Gilles Berdeaux
Journal:  BMC Ophthalmol       Date:  2008-07-15       Impact factor: 2.209

10.  Myo/Nog cells: targets for preventing the accumulation of skeletal muscle-like cells in the human lens.

Authors:  Jacquelyn Gerhart; Marvin Greenbaum; Victoria Scheinfeld; Paul Fitzgerald; Mitchell Crawford; Arturo Bravo-Nuevo; Meghan Pitts; Mindy George-Weinstein
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.